Corbion NV (NL:CRBN)
:CRBN
Want to see NL:CRBN full AI Analyst Report?
CRBN Stock Chart & Stats
€18.78
-€0.72(-3.46%)
At close: 4:00 PM EST
€18.78
-€0.72(-3.46%)
Day’s Range― - ―
52-Week Range€16.16 - €21.64
Previous CloseN/A
Volume184.39K
Average Volume (3M)126.91K
Market Cap
€1.12B
Enterprise Value€1.60B
Total Cash (Recent Filing)€44.70M
Total Debt (Recent Filing)€481.10M
Price to Earnings (P/E)15.0
Beta0.84
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.5%
Share Statistics
EPS (TTM)1.29
Shares Outstanding58,250,310
10 Day Avg. Volume117,838
30 Day Avg. Volume126,914
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€22.37Price Target Upside19.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)1.39
Revenue Forecast (FY)€1.28B
Bulls Say, Bears Say
Bulls Say
Balance-sheet DeleveragingMaterial debt reduction over 2023–2025 meaningfully lowers financial risk and increases strategic flexibility. Lower leverage supports capital allocation for R&D, bolt-on investments or continued dividend funding and reduces refinancing pressure across economic cycles.
Consistent Operating Cash GenerationSustained positive operating cash flow and a recovery to multi-year positive free cash flow indicate reliable internal funding. This cash generation supports working capital, debt reduction and strategic investment without sole reliance on external financing.
Specialty/product Market PositionLeadership in lactic-acid derivatives and preservation solutions gives durable B2B advantages: entrenched customer qualification cycles, formulation stickiness and exposure to food-safety trends and bio-based chemistry, supporting resilient demand from industrial food customers.
Bears Say
Multi-year Revenue SoftnessPersistent top-line decline over several years signals structural demand or market-share pressure. Weaker revenue limits scale economics, constrains operating leverage and makes durable margin expansion and predictable earnings growth more challenging.
Volatile Profitability And Cash SwingsWide swings in net income and free cash flow reduce visibility into sustainable earnings power. Earnings volatility can hamper long-term planning, weaken investor confidence and complicate reinvestment, dividend consistency and strategic commitments.
Smaller Asset Base And Unclear SustainabilityA contracting asset base may reflect lower capacity or divestments and raises questions about organic growth runway. Combined with uneven return metrics, it leaves uncertainty whether improved 2024 profitability can be sustained without renewed top-line expansion.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €16.16 and its highest was €21.64 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.12B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Aug 13, 2026 which is in 64 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Feb 26, 2026. The company reported €0.56 earnings per share for the quarter, beating the consensus estimate of N/A by €0.56.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Annually dividend of €1 which represents an annual dividend yield of 3.5%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.56 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.063%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion N.V. is a global entity specializing in the provision of a broad spectrum of ingredients, encompassing lactic acid and its derivatives, emulsifiers, functional enzyme mixtures, minerals, vitamins, and components sourced from algae. These innovative ingredient solutions, all derived from renewable resources, cater to diverse sectors such as the food industry, home and personal care, pharmaceuticals, animal feed, medical device manufacturing, and bioplastics. The company facilitates the distribution of its offerings through an extensive international network of sales offices and independent distributors. Established in 1919, the organization, formerly known as CSM N.V., officially adopted the name Corbion N.V. in October 2013, and its corporate base is located in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€22.37
▲(19.10% Upside)
Technical Analysis
Options Prices
Currently, No data available
---